Taiho’s Lytgobi Faces Heavy Competition, But Sets Efficacy Bar For Now

 
• By Alaric DeArment
  
Taiho Oncology won approval for Lytgobi in intrahepatic cholangiocarcinoma • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip